Amgen (AMGN) Change in Inventory (2009 - 2026)

Amgen has reported Change in Inventory for 18 years, with the latest figure at $31.0 million in Q2 2026.

• On a quarterly basis, Change in Inventory rose 112.97% year-over-year to $31.0 million in Q2 2026; TTM through Jun 2026 was -$346.0 million, a 77.4% increase from a year earlier, with the FY2025 full-year figure at -$886.0 million, up 65.01% from the prior year.
• Change in Inventory was $31.0 million for Q2 2026 at Amgen, up from -$18.0 million in the prior quarter.
• The five-year high for Change in Inventory was $241.0 million in Q3 2022, with the low at -$806.0 million in Q1 2024.
• Average Change in Inventory over 5 years is -$175.2 million, with a median of -$74.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Inventory soared 402.08% in 2022, then sank 2306.67% in 2024.
• Over 5 years, Change in Inventory stood at $91.0 million in 2022, then sank by 729.67% to -$573.0 million in 2023, then jumped by 43.63% to -$323.0 million in 2024, then surged by 63.16% to -$119.0 million in 2025, then jumped by 126.05% to $31.0 million in 2026.
• The last three Change in Inventory figures came in at $31.0 million (Q2 2026), -$18.0 million (Q1 2026), and -$119.0 million (Q4 2025), per Business Quant data.